171
Participants
Start Date
June 30, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
sunitinib malate
"* sunitinib malate oral starting dose 37.5 mg daily (continuous dosing).~* Dose may be decreased to 25 mg daily in case of adverse events.~* It may be increased to 50 mg daily if no response is seen after 8 weeks on treatment.~* Dosing to continue until unacceptable toxicity, progression of disease, death, or study termination."
Placebo
Placebo to match sunitinib taken daily (oral) on the same schedule as active agent below.
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Kwei-Shan
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Leuven
Pfizer Investigational Site, Perth
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Marseille
Pfizer Investigational Site, Rozzano (MI)
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Norfolk
Pfizer Investigational Site, Lübeck
Pfizer Investigational Site, Cremona
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Bordeaux
Pfizer Investigational Site, Marburg
Pfizer Investigational Site, Rennes
Pfizer Investigational Site, Iowa City
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Creve Coeur
Pfizer Investigational Site, City of Saint Peters
Pfizer Investigational Site, Lyon
Pfizer Investigational Site, Heidelberg
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Georgetown
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Ulm
Pfizer Investigational Site, Clichy
Pfizer Investigational Site, Bad Berka
Pfizer Investigational Site, Worcester
Pfizer Investigational Site, Worcester
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Leeds
Pfizer Investigational Site, Liverpool
Pfizer Investigational Site, Manchester
Lead Sponsor
Pfizer
INDUSTRY